These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11592118)

  • 1. Distribution of intraventricularly administered antiamyloid-beta peptide (Abeta) antibody in the mouse brain.
    Chauhan NB; Siegel GJ; Lichtor T
    J Neurosci Res; 2001 Oct; 66(2):231-5. PubMed ID: 11592118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice.
    Chauhan NB; Siegel GJ; Lichtor T
    J Neurosci Res; 2004 Dec; 78(5):732-41. PubMed ID: 15478192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
    Chauhan NB; Siegel GJ
    J Neurosci Res; 2003 Oct; 74(1):142-7. PubMed ID: 13130516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
    Chauhan NB; Siegel GJ
    J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of anti-Abeta antibody isotypes used for intracerebroventricular immunization in TgCRND8.
    Chauhan NB; Siegel GJ
    Neurosci Lett; 2005 Mar; 375(3):143-7. PubMed ID: 15694248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular passive immunization with anti-oligoAbeta antibody in TgCRND8.
    Chauhan NB
    J Neurosci Res; 2007 Feb; 85(2):451-63. PubMed ID: 17086547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
    Chauhan NB; Siegel GJ
    Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
    Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
    J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice.
    Farr SA; Banks WA; Uezu K; Sano A; Gaskin FS; Morley JE
    Life Sci; 2003 Jun; 73(5):555-62. PubMed ID: 12770611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intracerebroventricular injection of beta amyloid peptide (1-42) on caspase-3 activity, lipid peroxidation, nitric oxide and NOS expression in young adult and aged rat brain.
    Cetin F; Yazihan N; Dincer S; Akbulut G
    Turk Neurosurg; 2013; 23(2):144-50. PubMed ID: 23546897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.
    Levites Y; Smithson LA; Price RW; Dakin RS; Yuan B; Sierks MR; Kim J; McGowan E; Reed DK; Rosenberry TL; Das P; Golde TE
    FASEB J; 2006 Dec; 20(14):2576-8. PubMed ID: 17068112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice.
    Bard F; Fox M; Friedrich S; Seubert P; Schenk D; Kinney GG; Yednock T
    Exp Neurol; 2012 Nov; 238(1):38-43. PubMed ID: 22892246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
    Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
    Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
    Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads.
    Panza F; Frisardi V; Imbimbo BP; Seripa D; Solfrizzi V; Pilotto A
    Expert Opin Biol Ther; 2011 Jun; 11(6):679-86. PubMed ID: 21501112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.